Delivery Order SPE2DB20D2014-SPE2DB25FC86R
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $47,667.15 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child...
- The Defense Logistics Agency awarded a $25,946.28 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis without set-aside designation,...
- The Defense Logistics Agency awarded a $7,734.62 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine syringes. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.90 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its ongoing federal medical procurement activities...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $2,903.88 with a firm fixed price structure. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this competitively awarded contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $31,296 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of August 25, 2025. The contract, which is non-set-aside and competitively awarded, will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader contract vehicle with DLA. This award is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes valued at $1,078.23 under a firm fixed price contract. This non-set-aside award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order represents a discrete fulfillment under the company's broader contract vehicle with...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC86RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,827.32 to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form. This competitively awarded, firm fixed-price contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains through competitive open market awards. This Twinrix vaccine delivery order exemplifies the company's ongoing role as a key supplier within the DLA's medical supply chain, supporting military healthcare requirements both domestically and globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/28/25 |